Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients

World Journal of Gastroenterology

Volumn 12, Issue 26, 2006, Pages 4195-4198

  Leelawat, Kawin ^a,b   Leelawat, Surang ^c   Ratanachu Ek, Thawee ^a   Trubwongchareon, Somboon ^a   Wannaprasert, Jerasak ^a   Tripongkaruna, Saad ^a   Chantawibul, Suchart ^a   Tepaksorn, Panadda ^d  

^a RAJAVITHI HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c RANGSIT UNIVERSITY   (Thailand)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cholangiocarcinoma; hTERT; Real time reverse transcriptase polymerase chain reaction; Telomerase

Indexed keywords

CA 19-9 ANTIGEN; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT TUMOR; BLOOD ANALYSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SERUM; VOLUNTEER;

EID: 33748605027     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i26.4195     Document Type: Article

References (12)

1. Sriplung H, Sontipong S, Martin N, Wiangnon S, Vootiprux V, Cheirsilpa A, Kanchanabat C, Khuhaprema T. Cancer incidence in Thailand, 1995-1997. Asian Pac J Cancer Prev 2005; 6: 276-281
2. Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 2000; 7: 55-66
3. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004; 66: 167-179
4. Bachand F, Triki I, Autexier C. Human telomerase RNA-protein interactions. Nucleic Acids Res 2001; 29: 3385-3393
5. Yan P, Coindre JM, Benhattar J, Bosman FT, Guillou L. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res 1999; 59: 3166-3170
6. Johnson PJ, Lo YM. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 2002; 48: 1186-1193
7. Fleischhacker M, Beinert T, Ermitsch M, Seferi D, Possinger K, Engelmann C, Jandrig B. Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann N Y Acad Sci 2001; 945: 179-188
8. Novakovic S, Hocevar M, Zgajnar J, Besic N, Stegel V. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol Rep 2004; 11: 245-252
9. Mabruk MJ, O'Flatharta C. Telomerase: is it the future diagnostic and prognostic tool in human cancer? Expert Rev Mol Diagn 2005; 5: 907-916
10. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M, Anker P. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000; 6: 3823-3826
11. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005; 6: 611-622
12. Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma. Acta Otolaryngol 2005; 125: 409-414